PD-L1 Antibodies for EBV-Positive Gastric Cancer PD-L1 Antibodies for EBV-Positive Gastric Cancer

A case report suggests that checkpoint inhibitors may benefit EBV-positive gastric tumors.Journal of the National Cancer Institute

Source: Medscape Today Headlines - April 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news